Hyperlipidemias Clinical Trials

11 recruiting

Hyperlipidemias Trials at a Glance

11 actively recruiting trials for hyperlipidemias are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Beijing, Kolding, and Lewisburg. Lead sponsors running hyperlipidemias studies include Esperion Therapeutics, Inc., Johns Hopkins University, and Capital Medical University.

Browse hyperlipidemias trials by phase

Treatments under study

About Hyperlipidemias Clinical Trials

Looking for clinical trials for Hyperlipidemias? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hyperlipidemias trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hyperlipidemias clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

Penn Medicine Healthy Heart

HypertensionHyperlipidemias
University of Pennsylvania1,980 enrolled1 locationNCT06062394
Recruiting

Imaging the Pathogenesis of Cerebral Small Vessel Disease

HypertensionDiabetesHyperlipidemias+1 more
Johns Hopkins University50 enrolled1 locationNCT05703386
Recruiting
Not Applicable

Social Needs Screening and Chronic Diseases Study (WE CARE)

DepressionHypertensionDiabetes+2 more
University of Massachusetts, Worcester68,000 enrolled3 locationsNCT06903897
Recruiting

The Role of Proprotein-convertase-subtilisin/Kexin-type 9 in Kidney Damage in Nephrotic Syndrom

HyperlipidemiasNephrotic Syndrome
Kolding Sygehus75 enrolled1 locationNCT06373913
Recruiting
Not Applicable

Effect of ANKASCIN 568-P Products Regulating Blood Lipid

Hyperlipidemias
SunWay Biotech Co., LTD.80 enrolled1 locationNCT05737355
Recruiting
Early Phase 1

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Prostate CancerObesityMetabolic Syndrome+4 more
Western University30 enrolled1 locationNCT05802121
Recruiting
Not Applicable

Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients

Heart FailureObesityDepression, Anxiety+6 more
West Virginia School of Osteopathic Medicine95 enrolled1 locationNCT06049420
Recruiting
Not Applicable

PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI

Acute Coronary SyndromeHyperlipidemiasCardiovascular Events+1 more
Nanjing First Hospital, Nanjing Medical University1,212 enrolled1 locationNCT05457582
Recruiting
Not Applicable

Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients with Hyperlipidemia

Hyperlipidemias
Peking Union Medical College Hospital120 enrolled1 locationNCT05015348
Recruiting

Bempedoic Acid Pregnancy Surveillance Program

PregnancyHyperlipidemias
Esperion Therapeutics, Inc.20 enrolled1 locationNCT05103254
Recruiting

Integrated Diagnosis and Treatment of CKD on Outcomes

HypertensionChronic Kidney DiseasesHyperlipidemias+4 more
Capital Medical University1,000 enrolled1 locationNCT05242055